This playbook explores the benefits of building long-term site-network partnerships, with practical guidance from industry experts.
The average cost for a pharmaceutical company to develop a new asset has climbed to an all-time high. Regulations, the looming patent cliff, and the speed, predictability and quality of trials are all exerting pressure on development programs. As the need for scalable and efficient site management grows, strategic partnerships can help by building trust, consistency and scalability across multiple studies.
This playbook explores the benefits of building long-term site-network partnerships, with practical guidance from industry experts. To de-risk pipelines, sponsors and CROs need to rethink how they partner with clinical research sites. Highlights include:
- How partnering with a site network offers centralized operations, simplified contracting and faster startup.
- A fielded framework for achieving greater predictability, more consistent quality and more reliable outcomes in clinical research.
- A data-driven, ongoing approach that streamlines the feasibility phase.
Offered Free by: BioPharma Dive’s Studio by Informa TechTarget and Avacare
See All Resources from: BioPharma Dive’s Studio by Informa TechTarget and Avacare
